Healthcare Providers and Services
Company Overview of MultiPlan, Inc.
MultiPlan, Inc. provides healthcare cost management solutions through regional preferred provider organization networks in Wisconsin and the southwest. The company offers a single gateway to a host of network-and analytics-based solutions for managing the financial risks associated with healthcare claims; and products that fight waste, abuse, and fraud before payments are made. Its solutions include primary, complementary, and specialty networks, as well as non-network solutions, centers of excellence, network management services, and negotiation and medical reimbursement analyzing services. The company’s commercial solutions are aimed at companies and organizations that are responsible for ...
115 Fifth Avenue
New York, NY 10003
Founded in 1980
Key Executives for MultiPlan, Inc.
Chief Financial Officer and Executive Vice President
Chief of Operations and Executive Vice President
Senior Vice President and General Counsel
Chief Medical Officer, Corporate Medical Director, and Vice President
Compensation as of Fiscal Year 2015.
MultiPlan, Inc. Key Developments
Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services
Jun 16 15
Rosetta Genomics Ltd. announced that PersonalizeDx has executed a network participation agreement with MultiPlan, Inc. (MultiPlan) for the entire suite of PersonalizeDx testing and services effective July 1, 2015.
MultiPlan, Inc. Presents at Barclays High Yield Bond and Syndicated Loan Conference, Jun-11-2015 07:30 AM
May 22 15
MultiPlan, Inc. Presents at Barclays High Yield Bond and Syndicated Loan Conference, Jun-11-2015 07:30 AM. Venue: The Broadmoor Hotel, 1 Lake Avenue, Colorado Springs, Colorado, United States. Speakers: David Redmond, Chief Financial Officer and Executive Vice President.
GenomeDx Biosciences Enters into Contractual Agreement with MultiPlan, Inc. for Diagnostic Laboratory Testing
Sep 25 14
GenomeDx Biosciences announced that it has entered into contractual agreement with MultiPlan, Inc. for diagnostic laboratory testing. The agreement includes GenomeDx Bioscience's participation in the MultiPlan Network, expanding access to the Decipher(R) Prostate Cancer Classifier to health plan members who access the more than 500,000 providers participating in the MultiPlan Network. The Decipher prostate cancer classifier directly measures a patient's biological risk of developing metastatic prostate cancer. Together with coverage from existing networks, the contract brings coverage of the Decipher prostate cancer test to over 190 million lives.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|